Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Shares Outstanding (Weighted Average) (2021 - 2025)

Tenon Medical (TNON) has 5 years of Shares Outstanding (Weighted Average) data on record, last reported at $8250.0 in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 1349.91% year-over-year to $8250.0; the TTM value through Sep 2025 reached $8250.0, up 1349.91%, while the annual FY2024 figure was $1214.0, 434.8% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $8250.0 in Q3 2025 per TNON's latest filing, up from $7591.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $830000.0 in Q1 2021 and bottomed at $227.0 in Q4 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $45708.2, with a median of $919.0 recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 99.88% in 2022, then skyrocketed 1518.55% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $903.0 in 2021, then dropped by 11.3% to $801.0 in 2022, then crashed by 71.66% to $227.0 in 2023, then skyrocketed by 434.8% to $1214.0 in 2024, then surged by 579.57% to $8250.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $8250.0 in Q3 2025, $7591.0 in Q2 2025, and $3597.0 in Q1 2025.